Reducing ED visits by “closing the loop” for symptomatic patients.

2019 ◽  
Vol 37 (27_suppl) ◽  
pp. 100-100
Author(s):  
Edward Arrowsmith ◽  
Lenes Suits ◽  
Bertrand Marquess Anz ◽  
Gina Geren ◽  
Leslie Vasta ◽  
...  

100 Background: Improving the value provided to patients and payers in our system of cancer care relies on reduction of avoidable hospital and emergency department (ED) utilization. Furthermore, recent payer pressures on community oncology practices (COPs) have resulted in an increased focus on improving care coordination (CC) under strict resource constraints. As part of the ASCO Quality Training Program, we tested several low-cost CC interventions, leveraging workflow redesign, already employed care team members, and technology already implemented, to reduce ED visits (EDV) in a single large COP clinic where more than 3,200 cancer patients were treated during 2016. Methods: Baseline EDV rates were obtained through nurse chart review during Jan.-Jun. 2016. The following CC interventions were implemented: Initiated after hours call process with access to EMR and patient access to bidirectional real-time messaging with care team members; Implemented new in-office process to “close the loop” on patient evaluations by creating follow up guidelines for symptomatic telephone triage and in-clinic patient evaluations; Implemented a standard 48 hour follow up process for all EDV and hospital admissions; Increased patient awareness of telephone triage services during and after clinic hours by: augmenting new patient education by staff, developing a magnetic reminder to call the office for non-emergent and emergency situations, and instructions for use of afterhours call system. Nurse chart reviews were conducted throughout implementation to observe effects of new CC processes on EDV. Results: We observed a 30% reduction in EDV from baseline measurement. No new FTEs added and no new technology licenses acquired for this initiative. Conclusions: Low-cost CC interventions can be implemented in COPs to avoid ED utilization. Limitations of this analysis included manual chart abstraction that could not account for EDV outside the partnering health system, illustrating data access for hospital utilization remains a major challenge for quality improvement efforts for COPs. Additional challenges have been experienced in expanding these process improvements from a single large clinic to the broader Tennessee Oncology network of more than 30 clinics.

2021 ◽  
Vol 19 (1) ◽  
Author(s):  
Antonio Leon-Justel ◽  
Jose I. Morgado Garcia-Polavieja ◽  
Ana Isabel Alvarez-Rios ◽  
Francisco Jose Caro Fernandez ◽  
Pedro Agustin Pajaro Merino ◽  
...  

Abstract Background Heart failure (HF) is a major and growing medical and economic problem, with high prevalence and incidence rates worldwide. Cardiac Biomarker is emerging as a novel tool for improving management of patients with HF with a reduced left ventricular ejection fraction (HFrEF). Methods This is a before and after interventional study, that assesses the impact of a personalized follow-up procedure for HF on patient’s outcomes and care associated cost, based on a clinical model of risk stratification and personalized management according to that risk. A total of 192 patients were enrolled and studied before the intervention and again after the intervention. The primary objective was the rate of readmissions, due to a HF. Secondary outcome compared the rate of ED visits and quality of life improvement assessed by the number of patients who had reduced NYHA score. A cost-analysis was also performed on these data. Results Admission rates significantly decreased by 19.8% after the intervention (from 30.2 to 10.4), the total hospital admissions were reduced by 32 (from 78 to 46) and the total length of stay was reduced by 7 days (from 15 to 9 days). The rate of ED visits was reduced by 44% (from 64 to 20). Thirty-one percent of patients had an improved functional class score after the intervention, whereas only 7.8% got worse. The overall cost saving associated with the intervention was € 72,769 per patient (from € 201,189 to € 128,420) and €139,717.65 for the whole group over 1 year. Conclusions A personalized follow-up of HF patients led to important outcome benefits and resulted in cost savings, mainly due to the reduction of patient hospitalization readmissions and a significant reduction of care-associated costs, suggesting that greater attention should be given to this high-risk cohort to minimize the risk of hospitalization readmissions.


ORL ◽  
2021 ◽  
pp. 1-6
Author(s):  
Francesca Pirola ◽  
Armando De Virgilio ◽  
Alessandra Di Maria ◽  
Elena Russo ◽  
Matteo Di Bari ◽  
...  

Purpose: The aim of the study was to investigate the role of the exoscope as an assisting tool in endoscopic dacryocystorhinostomy (e-DCR). Materials and Methods: In this observational retrospective study, the application of the VITOM® exoscope was studied in a group of 21 patients undergoing mono- or bilateral DCR. The primary endpoint was to evaluate resolution of symptoms (epiphora/dacryocystitis) at the 6-month follow-up and time for surgery. Qualitative features of the exoscope (intraoperative view of the surgical field) and comparison with the typical setting for DCR were analyzed as secondary endpoints. A questionnaire was administered to surgical team members (ENT surgeon, ophthalmologist, and scrub nurse) to evaluate the perceived quality of this new technology (12 items valued as “good” = 2, “acceptable” = 1, and “not acceptable” = 0). A questionnaire score of 24 out of 24 was valued as “completely approved,” score 20–23 as “moderately approved,” and score ≤19 as “weakly approved.” Patients were divided into 3 consecutive groups, and questionnaire scores by each team member were analyzed for tendencies. Statistical analysis was performed to test significance at p < 0.05. Local Ethical Committee approval was obtained. Results: No significant differences were found between exoscope-set DCR and classic setting for concerned patient outcomes (failure rate: 3.2 vs. 3.8%, respectively, p = 0.896) and mean time for surgery (20’ vs. 23’, respectively, p = 0.091). The exoscope was valued by surgical team members as “completely approved” in 55.5% of cases, “moderately approved” in 39.7%, and “weakly approved” in 4.8%. Questionnaire scores by the ENT, ophthalmologist, and scrub nurse showed an average increase in the 3 consecutive groups (p = 0.119, p = 0.024, and p < 0.001, respectively). Conclusions: The exoscope is a new tool that may support e-DCR. It has no effects on symptom outcomes (epiphora/dacryocystitis) and time for surgery compared to classic DCR. Based on self-perception, this new technology was accepted by all team members.


2021 ◽  
Vol 39 (15_suppl) ◽  
pp. 12031-12031
Author(s):  
Ajeet Gajra ◽  
Marjorie E. Zettler ◽  
Amy R. Ellis ◽  
Kelly A. Miller ◽  
John G. Frownfelter ◽  
...  

12031 Background: An augmented intelligence (AI) tool using a machine learning algorithm was developed and validated to generate insights into risk for short-term mortality among patients with cancer. The algorithm, which scores patients every week as being at low, medium or high risk for death within 30 days, allowing providers to potentially intervene and modify care of those at medium to high risk based on established practice pathways. Deployment of the algorithm increased palliative care referrals in a large community hematology/oncology practice in the United States (Gajra et al, JCO 2020). The objective of this retrospective analysis was to evaluate the differences in survival and healthcare utilization (HCU) outcomes of patients previously scored as medium or high risk by the AI tool. Methods: Between 6/2018 – 10/2019, the AI tool scored patients on a weekly basis at the hematology/oncology practice. In 9/2020, a chart review was conducted for the 886 patients who had been identified by the algorithm as being at medium or high risk for 30-day mortality during the index period, to determine outcomes (including death, emergency department [ED] visits, and hospital admissions). Data are presented using descriptive statistics. Results: Of the 886 at-risk patients, 450 (50.8%) were deceased at the time of follow-up. Of these, 244 (54.2%) died within the first 180 days of scoring as at-risk, with median time to death 68 days (IQR 99). Among the 255 patients scored as high risk, 171 (67.1%) had died, vs. 279 (44.2%) of the 631 patients who were scored as medium risk (p < 0.001). Of the 601 patients who were scored more than once during the index period as medium or high risk, 342 (56.9%) had died, vs. 108 (37.9%) of the 285 who were scored as at risk only once (p < 0.001). A total of 363 patients (43.1%) had at least 1 ED visit, and 346 patients (41.1%) had at least 1 hospital admission. There was no difference in the proportion of patients scored as high risk compared with those scored as medium risk in ED visits (104 of 237 [43.9%] vs. 259 of 605 [42.8%], p = 0.778) or hospital admissions (100 of 237 [42.2%] vs. 246 of 605 [40.7%], p = 0.684, respectively). Compared with patients scored as medium or high risk only once during the index period, patients who were scored as at-risk more than once had more ED visits (282 of 593 [47.6%] vs. 81 of 249 [32.5%], p < 0.001) and hospital admissions (269 of 593 [45.4%] vs. 77 of 249 [30.9%], p < 0.001). Conclusions: This follow-up study found that half of the patients identified as at-risk for short-term mortality during the index period were deceased, with greater likelihood associated with high risk score and being scored more than once. Over 40% had visited an ED or were admitted to hospital. These findings have important implications for the use of the algorithm to guide treatment discussions, prevent acute HCU and to plan ahead for end of life care in patients with cancer.


2021 ◽  
pp. 089719002110106
Author(s):  
Nicholas J. Orvin ◽  
Janna C. Beavers ◽  
Stuart D. Russell

Background: Previous literature has suggested a potential diuretic sparing effect as early as 6 months following sacubitril-valsartan initiation in patients with heart failure with reduced ejection fraction (HFrEF); however, whether this effect manifests earlier after initiation is unclear. Objective: To evaluate the acute diuretic-sparing effects of sacubitril-valsartan. Methods: This was a single-center, retrospective analysis of outpatients with HFrEF initiated on sacubitril-valsartan with follow up within 90 ± 30 days and a concomitant loop diuretic prescription. The primary outcome was the percent of patients with an increase, decrease or no change in loop diuretic total daily dose (TDD). Key secondary outcomes included change in loop diuretic TDD (mg furosemide equivalents) and hospital admissions or emergency department (ED) visits. Results: A total of 145 patients were included (overall cohort) with 120 continuing sacubitril-valsartan at follow up (on-treatment cohort). In the on-treatment cohort, 20% (n = 24) had a reduction in loop diuretic TDD and 10% had an increase (n = 12). Median change in loop diuretic TDD was unchanged from baseline to follow up (p 0.13). In patients on >80 mg TDD of furosemide at baseline (n = 9), mean change was-53 ± 44 mg (p 0.006). Hospitalizations (6.2%) and ED visits (0.7%) for heart failure were infrequent. Conclusion: Patients may require a loop diuretic dose reduction within 2-3 months following sacubitril-valsartan initiation. This diuretic-sparing effect appears larger in those on higher baseline loop diuretic doses, and closer follow up may be warranted for these patients.


2017 ◽  
Vol 35 (8_suppl) ◽  
pp. 177-177
Author(s):  
Jorge Hirigoyen ◽  
Leonard A. Kalman ◽  
Jill Szymanski ◽  
Carmen Lazo ◽  
Christopher Espinosa ◽  
...  

177 Background: One of the biggest challenges for oncology patients is timely access to care. The inability to provide the right care for the right patient at the right time many times result in overuse of Emergency Departments (ED) to receive oncology care. Approximately 77% of oncology patients have an ER visit, and 63.2% of visits result in hospital admission (Mayer et al., 2011). Furthermore, the average cancer patient receiving chemotherapy has at least one hospital admission and two ED visits per year (Klodziej, et al., 2011). Establishing a “triage” program that attempts to avoid “avoidable” admissions can reduce unnecessary ED visits and associated inpatient care, therefore improving health outcomes while reducing costs. Methods: A quality improvement value-based care (VBC) initiative to prevent ED visits and avoid “avoidable” admissions, via an “Express Symptom Management Hotline” (ESMH) was created. ESMH provides oncology patients with direct and rapid phone access to an oncology Advanced Practice Provider (APP) who can appropriately triage a patient that is in need of acute symptom management. A patient can be managed over the telephone, with a clinic visit, and/or with other outpatient oncology same day services. A next day follow up call for triaged ensures that there was appropriate management. Telephone triage, associated early intervention by an APP for cancer related symptoms and a next day follow-up call will reduce ED visits and avoid “avoidable” admissions. Results: Among the 294 calls that were received from oncology patients for acute symptoms during a 12 week trial period, only 14 led to patients requiring ED services. All 14 ED visits required an admission. Conclusions: Telephone triage by APP’s via an ESMH can effectively manage oncology patients’ symptoms by providing early outpatient interventions. Such an ESMH helps avoid “avoidable” admissions, leading to improved health outcomes while reducing costs. [Table: see text]


2020 ◽  
Vol 4 (4) ◽  
pp. 664-667
Author(s):  
Anne Dulski ◽  
Vince Varamo

Introduction: Dermatology complaints account for 3.3% of emergency department (ED) visits per year. Most rashes are benign, but there are a select few that emergency physicians must be familiar with as delay in treatment could be life threatening. Case Report: A well-appearing, 76-year-old male presented to the ED with multiple coalescing pustules to his palms and soles and was transferred to the nearest tertiary care hospital for dermatology consult. He was diagnosed with palmoplantar pustulosis and discharged home with a five-day course of clobetasol propionate 0.05% cream twice daily and outpatient dermatology follow-up. Conclusion: Palmoplantar pustulosis is an uncommon skin condition characterized by recurrent eruptions of sterile pustules localized to the palms and soles. Emergency physician awareness of this rare diagnosis may help prevent hospital admissions and lead to earlier initiation of treatment with outpatient dermatology follow-up.


Stroke ◽  
2016 ◽  
Vol 47 (suppl_1) ◽  
Author(s):  
Andrew M Penn ◽  
Malcolm Maclure ◽  
Linghong Lu ◽  
Maximilian B Bibok ◽  
Jaclyn L Morrison ◽  
...  

Introduction: Transient neurological symptoms are a common presentation in emergency departments (ED). Access to stroke specialists and advanced imaging to identify acute cerebrovascular syndrome is resource intensive. Diversion to specialized TIA units improves logistics but incurs delay. Observational studies suggest efficacy of TIA units but are limited by sample size. We hypothesized that management through a centralized TIA service reduces risk of recurrent stroke. Methods: Vancouver Island (VI) introduced a centralized TIA unit in 2004 to which over 15,000 referrals (ED & GP) have been made. Long-term follow-up is possible as all VI residents (∼750,000) have one electronic health record for ED visits and hospital admissions. Large referral volumes and variable unit capacity have subjected patients to a wide range of delays-to-treatment. We used variation in secondary prevention delays to examine unit efficacy. We assessed hospitalized stroke and stroke death in all ED-referred patients comparing those seen in the unit within 90 days of symptom onset with those not seen within that time. Results: Between 2005 and 2013 there were 11,330 referrals, of which 4,017 were from the ED and referred within 2 weeks of symptom onset. The transition times between symptom onset, referral, arrival at the unit and stroke (or censoring time) were modeled using a multi-state model (Putter et al. 2007). Age, ABCDD, gender and the unit intervention were found to be associated with transition times. The hazard of stroke for patients who attended the unit was estimated as 30% that of those who did not attend (p=0.098). Predicted stroke-free survival curves are shown for a 70 year old woman. ARR at 90-days ranged from 4.2% downto 1.4% for High to Low ABCDD respectively. Conclusion: This large observational study reinforces published studies suggesting TIA units reduce risk of recurrent stroke within 90 days.


2021 ◽  
Author(s):  
Antonio Leon Justel ◽  
Jose Ignacio Morgado Garcia-Polavieja ◽  
Ana Isabel Alvarez Rios ◽  
Francisco Jose Caro Fernandez ◽  
Pedro Agustin Pajaro Merino ◽  
...  

Abstract BACKGROUND Heart failure (HF) is a major and growing medical and economic problem, with high prevalence and incidence rates worldwide. Cardiac Biomarker is emerging as a novel tool for improving management of patients with HF with a reduced left ventricular ejection fraction (HFrEF).METHODS This is a real-world, before and after interventional study, that assesses the impact of a personalized follow-up procedure for HF on patient’s outcomes and care associated cost, based on a clinical model of risk stratification and personalized management according to that risk. A total of 192 patients were enrolled and studied before the intervention and again after the intervention. The primary objective was the rate of readmissions, due to a HF. Secondary outcome compared the rate of ED visits and quality of life improvement assessed by the number of patients who had reduced NYHA score. A cost- analysis was also performed on these data. RESULTS Admission rates significantly decreased by 65,6% after the intervention, the total hospital admissions were reduced by 41% and the total length of stay was reduced by 46%. The rate of ED visits was reduced by 55%. Thirty-one percent of patients had an improved functional class score after the intervention, whereas only 7.8% got worse. The overall cost saving associated with the intervention was €139,717.65 for the whole group over 1 year.CONCLUSIONS A personalized follow-up of HF patients led to important outcome benefits and resulted in cost savings, mainly due to the reduction of patient hospitalization readmissions and a significant reduction of care- associated costs, suggesting that greater attention should be given to this high-risk cohort to minimize the risk of hospitalization readmissions.


2016 ◽  
Vol 12 (11) ◽  
pp. 1053-1058 ◽  
Author(s):  
Jenna S. Page ◽  
Lynne Lederman ◽  
Jamie Kelly ◽  
Maura M. Barry ◽  
Ted A. James

This article discusses the potential for shared mental models to improve teamwork during discharge planning and follow-up care. A 58-year-old inpatient on the hematology care unit of an academic medical center was discharged to his community after initial treatment of acute myeloid leukemia, without a clear plan for either discharge or follow-up. This case highlights the challenges faced by the primary oncology care team, the patient’s community health-care team, the patient, and his caregiver, because a formal plan for follow-up care after discharge was not in place. The lack of communication within the oncology care team and between the medical center and community care teams that leads to the gap in continuity of care between inpatient and outpatient oncology settings could be addressed at least in part by establishing a shared mental model. This model would require all individuals involved in patient care to recognize they are part of a team. Furthermore, all members of the interdisciplinary discharge team need to understand their own roles and responsibilities as well as those of the other team members, including the need for communication and how their roles and activities affect those of other team members. Tools such as huddles, checklists, and patient education could be used to help the team recognize and achieve its goals. Ideally, this shared mental model could be extended to include the community health-care team, leading to a more fluid transition between inpatient and outpatient care, improving patient satisfaction, and likely improving patient outcomes.


Diabetes ◽  
2018 ◽  
Vol 67 (Supplement 1) ◽  
pp. 2317-PUB
Author(s):  
RAJESH GARG ◽  
SHREYA BHANDARI ◽  
RAQUEL REIN ◽  
MARIE E. MCDONNELL

Sign in / Sign up

Export Citation Format

Share Document